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Abstract
Objective: To investigate the role of different anger variables in predicting quality of life and mood in multiple
sclerosis (MS), while controlling for disease severity.
Methods: 78 individuals with MS completed questionnaire measures of anger (Anger Rumination Scale and
State/Trait Anger Expression Inventory), mood (Hospital Anxiety and Depression Scale); disease severity (Patient
Determined Disease Steps) and quality of life (WHOQoL-BREF).
Results: Anger was significantly associated with quality of life (QoL) in MS. Higher levels of experienced anger
and lack of control over the experience of anger predicted lower psychological and environmental QoL. Depression
levels were also predicted by high levels of experienced anger and lack of control over anger. In contrast, ruminating
about anger was the strongest predictor of anxiety levels.
Conclusions: The results demonstrate that feelings of anger are strongly associated with QoL in MS, even when
disease severity is taken into account. Problems in controlling and ruminating about anger may also contribute to
mood disorder in MS.
Keywords: Anger; Rumination; Depression; Anxiety; Quality of Life;
Multiple Sclerosis
Introduction
Multiple Sclerosis (MS) is a chronic demyelinating disease of the
central nervous system that causes various neurological impairments.
As well as the health challenges faced by those with MS, the disease is
also associated with emotional disturbances. Depression, anxiety,
anger and irritability are frequently reported in MS patients [1-4].
People with MS often report feelings of anger and irritation, and
anecdotally, this appears to negatively impact their overall quality of
life (QoL) and increases feelings of depression and anxiety. MS
patients often report reduced QoL compared, not only to the general
population, but also patients with other chronic diseases [5]. Yet few
studies have examined the role of anger in QoL and mood disorder in
individuals with MS, therefore that is the focus of the current research.
Anger is one of the most frequently experienced negative emotions
[6] and can have serious negative effects on everyday life [7].
Expressing anger is specifically associated with interpersonal
difficulties, such as social maladjustment, while expressing other
negative emotions such as fear and sadness are not [8,9]. However,
evidence suggests uninhibited expressions of anger, or chronic
suppression of anger, may also be detrimental to an individual’s
physical health [10-12], social involvement [13,14] and close personal
relationships [15-17]. Moreover, anger inducing situations often lead
to rumination, i.e. recurrent thoughts about the causes and
consequences of the event, which have also been shown to have
maladaptive consequences, such as elevated blood pressure [18] and
an increase in depressed mood [19]. Therefore it is apparent that anger
has negative consequences both physiologically and psychologically
for individuals, yet this could be a greater risk in clinical populations
where feelings of anger may be more heightened.
Heightened anger has been observed amongst clinical populations
with similar disease progression to MS, including arthritis [20,21],
fibromyalgia [22] and chronic pain [23,24]. The frustrations of people
suffering from such illnesses, such as persistent bodily complaints, and
limited feedback on the aetiology and progression of their illness [23]
are likely to be similar for individuals with MS. In addition to the
heightened anger associated with the reactive response to the illness,
brain specific lesions in MS might also influence the experience and
control of emotions such as anger [25]. As anger has been associated
with depressed mood [19] and there is a lifetime prevalence of
depression in MS as high as 50% [26-28], understanding links between
anger and depression in MS is important.
Currently there is a paucity of research investigating anger and MS
in any depth. Nocentini and colleagues [1] assessed anger in 195
participants with MS, in relation to demographic, clinical and mood
characteristics. Anger was assessed using the State Trait Anger
Expression Inventory (STAXI). Their results suggested higher levels of
withheld anger and lower levels of controlled anger than might be
expected in the general population, independent of disease severity.
Significant associations between anger, anxiety and depression were
reported. Consequently, there appears to be some evidence that, not
only is anger experienced more in MS than in the general population,
but anger is significantly associated with negative affect. However this
study did not explore the issue of anger rumination, which is likely to
be particularly important in the development of anxiety and
depression. Also to date, there appear to be no studies examining how
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anger experience and control influences QoL in people with MS.
Therefore, this study will examine the link between anger experience/
control and QoL in people with MS. Given the very individual nature
of MS, it is likely that some people with the condition will not
experience unusual levels of anger, whilst others experience serious
problems with this emotion, and the current study aims to explore
this. By using multidimensional assessments of anger we will explore
which aspects of anger are most important in predicting QoL. The
STAXI-2 [29] separates out the different processes which might be
involved in the internal experience of anger (AX-I) from the outward
expression of anger through aggression (AX-O). It also assesses how
people control their anger: whether through internal control strategies
such as counting to ten (AC-I), or through the active suppression of
outward expression (AC-O). Our other assessment of anger is the
Anger Rumination Scale [30] which measures the extent to which
people ruminate about feelings of anger or frustration.
The possible links between these different aspects of anger and QoL
will be explored. In the current study we used the WHOQoL-BREF
[31] which assesses four sub-domains of self-reported QoL: physical
(e.g. energy levels), psychological (e.g. self-esteem), social (e.g.
personal relationships) and environmental (e.g. finances). The
WHOQoL-BREF identifies psychosocial effects of MS which might
otherwise go unnoticed, and there is evidence of good validity of this
measure in MS populations (in terms of substantial correlations with
depression and disability, as well as caregiver assessments of QoL)
[32]. It was hypothesised that people with MS who reported
experiencing feelings of anger or lack of control over their anger would
also report lower QoL. We used regression analyses to explore which
aspects of anger were the strongest predictors of QoL, taking into
account individual differences in disease severity. We also explored the
links between anger experience and control and mood in MS by
assessing anxiety and depression levels.
Method
Participants
300 participants from the NHS Grampian MS database were
contacted, 85 of whom gave their consent (28% response rate). Seven
were excluded: 5 due to incomplete data and 2 due to substance abuse,
yielding a sample of 78 participants (64 female, mean age=46.0;
SD=10.06; range 24-68 years). Mean years education was 14.77 years
(SD=3.33). Mean disease duration was 11.18 years (SD=7.09). Fifty
participants had the relapsing-remitting form of the disease, 21
participants had the progressive type, whilst for 7 participants disease
type was not recorded.
Materials and Procedure
Participants were sent questionnaire packs containing the following
measures: World Health Organisation Quality of Life Questionnaire
(WHOQoL-BREF) [31]. This required participants to rate aspects of
their QoL over the previous two weeks. Four distinct domains of QoL
(physical, psychological, social, environmental) were assessed using 24
questions. Higher scores represent higher QoL, with scores calculated
from 0-100.
Anger Rumination Scale (ARS): This 19-item scale measures the
tendency to focus on angry episodes, recall past anger experiences and
think about causes and consequences of anger. It was developed to
assess the cognitive processes that unfold after the emotion of anger
has been triggered. Here, we combined the four domains of the ARS
(Angry Afterthoughts, Thoughts of Revenge, Angry Memories and
Understanding of Causes) to form one total score. Higher scores
represent a greater overall tendency to focus on angry moods, recall
past anger episodes, and think over the causes and consequences of
anger episodes [30].
State/Trait Anger Expression Inventory-2 (STAXI-2): This
questionnaire comprises 57 items measuring anger experience and
control on six subscales: State Anger: the intensity of feeling; Trait
Anger: anger as a personality trait; Anger Expression-Out: the
tendency to express the anger externally; Anger Expression-In: the
tendency to experience anger internally but not show it externally;
Anger Control-Out: the control of external anger expression and
Anger Control-In: the control of internalised anger. High scores on
the first four sub-scales demonstrate a greater tendency to experience
or express anger, whereas high scores on the latter two sub-scales
(Anger Control In and Out) demonstrate an increased tendency
towards controlling anger. In the present study all scales were
administered (totalling 41 items) with the exception of the State Anger
scale; as pilot work in the department has indicated that it revealed
floor effects [33]. The STAXI-2 has been found to be a valid, reliable
measure of the constructs it was intended to represent [29].
Hospital Anxiety and Depression Scale (HADS): This well validated
14-item measure is used to assess current levels of anxiety and
depression. Individuals are asked to indicate which response comes
closest to how they have been feeling in the past week. Higher scores
indicate the increased presence of anxiety and/or depression [34].
Patient Determined Disease Steps (PDDS): This measure assesses
disease progression in MS on an 8 item scale from ‘Normal’ through to
‘Confined to wheelchair’. The PDDS has been found to be user-
friendly, produce evenly distributed scores and correlate highly with
the clinician assessed Kurzke Expanded Disability Status Scale (EDSS)
[35-38].
Results
Table 1 shows descriptive statistics and correlations between
dimensions of anger (STAXI and ARS) and QoL. Higher levels of trait
anger were associated with lower perceived QoL across all domains,
with the exception of physical QoL. Those who expressed higher levels
of anger also reported lower psychological, social and environmental
QoL, regardless of whether anger was experienced inwardly (Anger
Exp. In) or expressed outwardly (Anger Exp. Out). Poor physical QoL
was associated with experiencing anger inwardly, but not expressing it
outwardly. Conversely, high levels of control over anger correlated
positively with QoL across all domains, with the exception of physical
QoL. Control of the inner experience of anger (Anger Control In) and
control of the outward display of anger (Anger Control Out) were
associated with good psychological and environmental QoL. However,
only the control of outward anger was significantly associated with
social QoL.
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QoL Scale
M SD Phys Psych Soc Environ
STAXI:
Trait Anger 14.68 4.83 -.165 -.509** -.384** -.482**
Anger Exp. Out 13.42 3.54 -.103 -.415** -.334** -.399**
Anger Exp. In 16.32 4.74 -.256* -.560** -.395** -.495**
Anger Control Out 24.67 5.28 .146 .282* .178 .342**
Anger Control In 22.54 5.05 .166 .345** .231* .406**
ARS Total 31.27 11.86 -.314** -.558** -.283* -.457**
Note: * p<.05, ** p<.01. M 13.05 13.76 15.28 15.81
SD 2.41 3.99 4.11 3.39
Table 1: Descriptive statistics and Pearson correlations between anger variables (STAXI and ARS) and QoL dimensions.
With respect to the ARS, those who reported the tendency to
ruminate on angry episodes also reported experiencing lower QoL, in
particular psychological and environmental aspects. Table 2 shows the
relationships of the anger measures with anxiety, depression and
disease severity. Both anxiety and depression correlated highly with
the anger measures, with higher levels of mood symptoms associated
with greater trait anger, more expression of anger, and less control
over anger. Ruminating on angry experiences was highly correlated
with mood, particularly anxiety.
Severity HADS-Anxiety HADS-Depression
STAXI:
Trait Anger .408** .599** .502**
Anger Exp. Out .348** .525** .417**
Anger Exp. In .247** .446** .612**
Anger Control Out .439** -.360** -.353**
Anger Control In -.240* -.251** -.382**
ARS Total .461** .699** .558**
Note: * p<.05, ** p<01. M 20.17 16.36 11.97
SD 12.85 2.91 4.19
Table 2: Descriptive statistics and Pearson correlations between dimensions of anger, PDDS severity measure and HADS measures of anxiety and
depression.
In order to investigate whether the anger variables predicted QoL,
taking into account disease severity, a series of hierarchical regression
analyses were carried out (Table 3). Each measure of QoL (physical,
psychological, social, environmental) was treated as a separate
dependent variable. As a first step in each regression, ratings of disease
severity were entered. Step two included anger rumination total scores
(ARS), and the measures from the STAXI (trait anger, anger
expression in and out, anger control in and out) as predictors. Note
that the regression statistics indicated that multicollinearity was not
present in these analyses. Disease severity was the only significant
predictor of physical QoL, and the anger variables did not explain
additional variance. Disease severity was also a predictor of both
psychological QoL and environmental QoL. Both aspects of QoL
showed a similar pattern: disease severity explained a significant
portion of the variance in QoL, as did the anger variables. In
particular, frequent internal experiences of anger were associated with
lower reported levels of psychological and environmental QoL and
greater internal control of anger was associated with higher reported
levels of these aspects of QoL. While anger variables added
significantly to the variance in social QoL explained by disease
severity, none of the individual anger measures reached significance.
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QoL Scale
Physical Psychologic
al
Social Environment
al
Predictors: Step 1
Severity (β) -.697** -.597** -.335** -.593**
F (1,77) 71.99** 42.13** 9.59** 41.18**
R2 .49 .36 .11 .35
Predictors: Step 2
Severity (β) -.737** -.371** -.191 -.430**
Rumination (β) -.113 -.158 .125 -.005
Trait Anger (β) .302 -.048 -.204 -.011
Anger Exp In (β) .004 -.250* -.223 -.217*
Anger Exp Out (β) -.014 -.156 -.226 -.171
Anger Control In (β) .123 .284* .220 .331**
Anger Control Out
(β) .038 -.256 -.299 -.154
F (6,70) 11.10** 12.98** 3.66** 10.86**
R2 change .04 .21** .16* .17**
Table 3: Regression analyses for QoL domains as indexed by the
WHOQoL. Step 1 indicates prediction of QoL by disease severity. The
contribution of anger variables in predicting the subscales of QoL
(over and above disease severity) is indicated by significant individual
β-weightings, and the significance of F values at Step 2 in the analyses.
Similar regression analyses were carried out to look at whether the
experience and regulation of anger in MS explained variance in
anxiety or depression levels (Table 4). Anger variables explained
significant variance in anxiety, even taking into account disease
severity. Specifically, rumination on angering experiences was a highly
significant predictor of anxiety levels. Anger variables also significantly
predicted depression, over and above the contribution made by disease
severity. In this case, high levels of internal experience of anger, and a
lack of feeling of control over those internal experiences both
contributed to variance in depression.
HADS-Anxiety HADS-Depression
Predictors: Step 1
Severity (β) .478** .631**
F (1,77) 22.53** 50.22**
R2 .23 .40
Predictors: Step 2
Severity (β) .190 .399**
Rumination (β) .386** .140
Trait Anger (β) .197 -.105
Anger Exp In (β) .029 .344**
Anger Exp Out (β) .148 .136
Anger Control In (β) -.002 -.268**
Anger Control Out (β) .082 .080
F (6,70) 11.22** 16.23**
R2 change .30** .22**
Note: * p<.05, ** p<.01.
Table 4: Regression analyses for anxiety and depression as indexed by
HADS. The contribution of anger variables in predicting the subscales
of QoL is indicated by significant individual β-weightings, and the
significance of F values at Step 2 in the analyses.
Discussion
These results add to the literature by indicating that anger is an
important predictor of QoL in people with MS. Psychological and
environmental QoL were strongly associated with everyday level of
anger (as assessed by trait anger), high levels of experienced and
expressed anger, lack of control over anger, and a tendency to
ruminate on angering experiences. Poorer physical QoL was correlated
with a tendency to experience anger inwardly and ruminate on anger.
Social QoL was associated with all aspects of anger except the control
of outward expression. All aspects of anger were significantly related
to anxiety and depression ratings. This suggests that the tendency
amongst people with MS to experience mood disturbances such
feelings of anger and frustration reported in previous studies [1-4] is
strongly associated with poorer overall well-being and key patient
centred outcomes. The findings reported are consistent with empirical
evidence revealing that people with MS report experiencing low QoL
[5].
Regression analyses were used to help understand which aspects of
anger were most important in predicting QoL and mood in MS, in
addition to variance explained by disease severity. Results indicated
that anger variables explained variance in most domains of QoL over
and above the prediction from disease severity. This indicates that
links between anger experience/control and QoL in MS are not driven
solely by individuals simply experiencing greater levels of disease
related symptoms. Use of the STAXI and Anger Rumination Scales
allowed us to look in more detail at which aspects of anger were more
important in predicting QoL. For both psychological and
environmental QoL, the key aspects of anger were frequent internal
experiences of anger and lack of ability to control this inner experience
of anger. To be more specific, high levels of experienced anger were
associated with lower levels of psychological and environmental QoL,
whereas higher levels of internal anger control were associated with
higher levels of QoL in these domains. It is notable that the internal
experience and internal control over anger were more important than
experiencing and controlling the outward display of anger. This
suggests that internal experiences of anger might adversely impact on
well-being in people with MS, while having a sense of control over
angry feelings might improve QoL. This could be a potential area for
future intervention in management of the disease. It was also
interesting to note that, when disease severity was controlled for,
rumination ceased to be a significant predictor of poor QoL. These
results therefore suggest that the extent to which disease related
symptoms are experienced has a greater influence on individuals’ self-
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rated QoL than the extent to which they dwell on angry feelings or
episodes.
Anger variables were associated with higher levels of anxiety and
depression in the current sample. Regression analyses revealed that
levels of depression were again predicted by frequent internal
experience of angry emotions, and a lack of sense of internal control
over anger. In contrast, anxiety levels were strongly predicted by the
tendency to ruminate over angering experiences. This has potential
implications for therapeutic interventions in MS for people who are
experiencing distress related to their illness. Focusing on the inner
control of anger and the tendency to ruminate on frustration could
help to improve mood.
These findings extend previous research demonstrating the possible
maladaptive consequences of both the suppression and expression of
anger [10-17]. In the current study the internalised aspects of anger
(inner experience, inner control, and rumination) were more
important in predicting mood and well-being than more external
aspects such as displaying emotion. One important caveat to the
current study is the reliance on self- report questionnaires, which are
subject to mood-related biases and anosognosia. While outward
expression of anger might be assessed using relative reports, it is
difficult to assess the inner experience of emotions or the control
strategies used in any other way than relying on self-report.
These results build on other studies which suggest that emotional
skills are likely to be important in influencing QoL in MS. Previous
research indicates that problems with emotion regulation and emotion
perception predict impaired QoL in people with MS [38-40]. The
current results again indicate that problems with emotional skills in
MS, such as experiencing and controlling anger, predict QoL, anxiety
and depression, independently of current assessment of disease
severity. Thus, while most measures of disease severity in MS focus
mainly on physical symptoms of the disease, there is a clear need to
understand more about emotional and social skills to address QoL in
people with MS. One issue with all of these studies to date is that the
cross-sectional nature of the research makes it difficult to draw
conclusions about causality. Given the often fluctuating nature of MS
symptoms, it will be an important task for future research to explore
the temporal nature of the relationship between emotions and QoL in
MS; perhaps through the use of experience sampling methods.
Longitudinal methods might also help to tease apart how coping with
intense emotional issues raised by living with a lifelong degenerative
condition relate to the experience of anger. Given that the experience
and control of anger might be influenced by changes in the
neurocognitive systems involved in self-regulation in MS, it would also
be useful in future studies to include assessments of cognitive
measures, as well as brain scan information.
Conclusions
Most measures of disease severity in MS focus solely on physical
symptoms of the condition. The current study indicates that frequent
experiences of anger, along with a lack of control over anger
contribute to QoL in MS. It is important, therefore, that emotional
issues are more widely assessed and discussed by clinicians and those
with MS, as they might influence well-being as much as the more
widely recognised motor symptoms.
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